Objective:

To explore the mechanisms behind diabetes-induced cardiomyopathy (DbCM) and its progression to heart failure with preserved ejection fraction (HFpEF), focusing on calcium handling.

Approach:

Key Findings:

• Diabetes, particularly type 2 diabetes (T2D), is a significant risk factor for cardiovascular disease and heart failure.
• Impairment of calcium-handling proteins like SERCA2a and RyR2 contributes to cardiac dysfunction in DbCM.
• Current understanding of DbCM is limited, and no viable cures exist to reverse its progression.

Interpretation:

Insulin resistance in diabetes leads to cardiac impairment, with calcium mishandling being a critical factor in the development of DbCM and HFpEF.

Limitations:

• The complexity of DbCM and its mechanisms is not fully understood.
• Further studies are needed to clarify the impact of calcium-handling proteins on DbCM progression.

Conclusion:

The review highlights the need for targeted treatments at the molecular level to address both diabetes and heart failure.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.